Wai Chun Bio-Technology Limited

Equities

660

KYG9450C1107

Specialty Chemicals

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
0.1 HKD +17.65% Intraday chart for Wai Chun Bio-Technology Limited -27.54% -30.56%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wai Chun Bio-Technology Limited Announces Change of Independent Non-Executive Director CI
Wai Chun Bio-Technology Limited Announces Company Secretary Changes CI
Wai Chun Bio-Technology's Fiscal H1 Attributable Loss Narrows MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Wai Chun Bio-Technology Limited Announces Change of Company Secretary and Authorised Representative CI
Winding-Up Petition Against Wai Chun Bio-Technology Withdrawn MT
Wai Chun Bio-Technology Names Controlling Shareholder's Son as Chairman/CEO MT
Wai Chun Bio-Technology Limited Announces Appointment of Lam Ka Chun as Chief Executive Officer CI
Wai Chun Bio-Technology Limited Announces Appointment of Lam Ka Chun as Chairman of the Board CI
Wai Chun Bio-Technology Incurs Loss in Fiscal Year 2023 MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Wai Chun Bio-Technology Limited Announces Board Changes CI
Wai Chun Bio-Technology Limited Announces Change of Company Secretary and Authorised Representative CI
Wai Chun Bio-Technology Limited Announces Change of Head Office and Principal Place of Business in Hong Kong CI
Wai Chun Bio-Technology Limited Announces Management Changes CI
Wai Chun Bio-Technology's H2 2022 Loss Widens MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Wai Chun Bio-Technology Limited Announces Executive Changes CI
Wai Chun Bio-Technology Limited Auditor Raises 'Going Concern' Doubt CI
Wai Chun Bio-Technology to Widen Loss during 18 Months Ended June 30 MT
Wai Chun Bio-Technology Limited Provides Earning Guidance for Eighteen Months Ended 30 June 2022 CI
Wai Chun Bio-Technology Limited Announces Delay in Publication of the Audited Annual Results and Annual Report CI
Wai Chun Bio-Technology Limited Announces Board Changes CI
Wai Chun Bio-Technology Limited Announces Appointment of Independent Non-Executive Director and Change in Composition of Board Committees CI
Wai Chun Bio-Technology Limited Reports Earnings Results for the Eighteen Months Ended June 30, 2022 CI
Chart Wai Chun Bio-Technology Limited
More charts
Wai Chun Bio-Technology Ltd is a Hong Kong-based investment holding company principally engaged in the manufacture and sale of modified starch. Together with its subsidiaries, the Company is principally involved in the manufacture and sale of modified starch and other biochemical products, , such as biochemical refined oil products. In addition, the Company is also involved in the trading of electronic parts, components and electrical appliances.
More about the company
  1. Stock Market
  2. Equities
  3. 660 Stock
  4. News Wai Chun Bio-Technology Limited
  5. Wai Chun Bio-Technology's Fiscal H1 Attributable Loss Narrows